Baxter Gross Margin 2010-2024 | BAX

Current and historical gross margin for Baxter (BAX) over the last 10 years. The current gross profit margin for Baxter as of December 31, 2024 is %.
Baxter Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-12-31 $10.64B $3.98B 37.46%
2024-09-30 $10.64B $4.56B 42.83%
2024-06-30 $10.54B $4.58B 43.46%
2024-03-31 $10.44B $4.26B 40.83%
2023-12-31 $10.36B $4.15B 40.06%
2023-09-30 $8.97B $3.23B 35.99%
2023-06-30 $9.98B $3.22B 32.24%
2023-03-31 $9.86B $3.48B 35.24%
2022-12-31 $10.06B $3.55B 35.29%
2022-09-30 $13.79B $4.79B 34.71%
2022-06-30 $13.40B $5.06B 37.76%
2022-03-31 $12.91B $4.92B 38.14%
2021-12-31 $12.15B $4.72B 38.86%
2021-09-30 $12.45B $4.89B 39.27%
2021-06-30 $12.20B $4.76B 39.06%
2021-03-31 $11.82B $4.57B 38.66%
2020-12-31 $11.67B $4.59B 39.30%
2020-09-30 $11.53B $4.69B 40.71%
2020-06-30 $11.41B $4.73B 41.45%
2020-03-31 $11.53B $4.84B 42.03%
2019-12-31 $11.36B $4.76B 41.90%
2019-09-30 $11.14B $4.64B 41.62%
2019-06-30 $11.05B $4.64B 41.97%
2019-03-31 $11.06B $4.73B 42.72%
2018-12-31 $11.10B $4.76B 42.88%
2018-09-30 $11.08B $4.75B 42.91%
2018-06-30 $11.02B $4.65B 42.19%
2018-03-31 $10.79B $4.54B 42.13%
2017-12-31 $10.58B $4.47B 42.27%
2017-09-30 $10.43B $4.41B 42.31%
2017-06-30 $10.28B $4.36B 42.35%
2017-03-31 $10.26B $4.20B 40.87%
2016-12-31 $10.16B $4.12B 40.50%
2016-09-30 $10.12B $4.08B 40.31%
2016-06-30 $10.05B $4.04B 40.23%
2016-03-31 $9.94B $4.09B 41.17%
2015-12-31 $9.97B $4.15B 41.59%
2015-09-30 $10.15B $4.28B 42.16%
2015-06-30 $10.38B $4.44B 42.79%
2015-03-31 $12.06B $5.39B 44.70%
2014-12-31 $13.50B $6.26B 46.37%
2014-09-30 $15.03B $7.05B 46.89%
2014-06-30 $16.03B $7.76B 48.41%
2014-03-31 $15.55B $7.73B 49.73%
2013-12-31 $15.15B $7.60B 50.15%
2013-09-30 $14.33B $7.34B 51.23%
2013-06-30 $14.09B $7.24B 51.39%
2013-03-31 $14.00B $7.18B 51.27%
2012-12-31 $13.94B $7.13B 51.19%
2012-09-30 $14.03B $7.16B 51.04%
2012-06-30 $14.03B $7.12B 50.75%
2012-03-31 $14.00B $7.09B 50.62%
2011-12-31 $13.89B $7.05B 50.72%
2011-09-30 $13.80B $6.90B 50.00%
2011-06-30 $13.54B $6.79B 50.12%
2011-03-31 $13.20B $6.59B 49.92%
2010-12-31 $12.84B $5.96B 46.39%
2010-09-30 $12.82B $6.11B 47.66%
2010-06-30 $12.74B $6.08B 47.74%
2010-03-31 $12.67B $6.08B 48.01%
2009-12-31 $12.56B $6.53B 51.94%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $14.818B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $227.162B 27.40
Boston Scientific (BSX) United States $140.689B 37.90
Stryker (SYK) United States $132.255B 28.42
EssilorLuxottica (ESLOY) France $128.431B 0.00
Medtronic (MDT) Ireland $105.938B 15.47
Lonza Group Ag (LZAGY) Switzerland $47.424B 0.00
Haleon (HLN) United Kingdom $46.151B 26.20
ResMed (RMD) United States $31.269B 24.08
Agilent Technologies (A) United States $29.217B 19.30
GE HealthCare Technologies (GEHC) United States $28.556B 13.89
Terumo (TRUMY) Japan $28.160B 0.00
Koninklijke Philips (PHG) Netherlands $22.192B 15.85
Zimmer Biomet Holdings (ZBH) United States $19.373B 12.24
Insulet (PODD) United States $17.332B 74.11
Smith & Nephew SNATS (SNN) United Kingdom $11.356B 0.00
Sunny Optical Technology (SNPTF) China $7.609B 0.00
Lantheus Holdings (LNTH) United States $6.938B 17.06
Bio-Rad Laboratories (BIO) United States $6.672B 23.10
Demant (WILYY) Denmark $6.644B 0.00
Prestige Consumer Healthcare (PBH) United States $3.977B 18.98
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Perrigo (PRGO) Ireland $3.455B 9.89
ICU Medical (ICUI) United States $3.400B 29.07
Haemonetics (HAE) United States $2.872B 13.52
Envista Holdings (NVST) United States $2.614B 20.80
GN Store Nord (GNNDY) Denmark $2.188B 14.75
LeMaitre Vascular (LMAT) United States $1.946B 44.47
QuidelOrtho (QDEL) United States $1.698B 14.22
AtriCure (ATRC) United States $1.565B 0.00
Kestra Medical Technologies (KMTS) United States $1.214B 0.00
Green Thumb Industries (GTBIF) United States $1.189B 18.67
AdaptHealth (AHCO) United States $1.051B 10.12
BioLife Solutions (BLFS) United States $1.041B 0.00
InMode (INMD) Israel $1.038B 8.67
Neogen (NEOG) United States $0.953B 12.19
Phibro Animal Health (PAHC) United States $0.700B 10.74
Evolus (EOLS) United States $0.686B 0.00
Curaleaf Holdings (CURLF) Canada $0.649B 0.00
Valneva SE (VALN) France $0.552B 0.00
Owens & Minor (OMI) United States $0.535B 4.56
CeriBell (CBLL) United States $0.532B 0.00
Capricor Therapeutics (CAPR) United States $0.514B 0.00
Tilray Brands (TLRY) Canada $0.453B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.450B 0.00
Surmodics (SRDX) United States $0.394B 0.00
Omeros (OMER) United States $0.394B 0.00
SNDL (SNDL) Canada $0.368B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Cresco Labs (CRLBF) United States $0.328B 0.00
VAREX IMAGING (VREX) United States $0.302B 13.07
Viemed Healthcare (VMD) United States $0.262B 23.68
Sanara MedTech (SMTI) United States $0.262B 0.00
ZimVie (ZIMV) United States $0.261B 15.65
Sanuwave Health (SNWV) United States $0.256B 0.00
Verano Holdings (VRNOF) United States $0.251B 0.00
Aurora Cannabis (ACB) Canada $0.250B 44.40
Cerus (CERS) United States $0.242B 0.00
OraSure Technologies (OSUR) United States $0.224B 0.00
Quanterix (QTRX) United States $0.200B 0.00
Canopy Growth (CGC) Canada $0.189B 0.00
High Tide (HITI) Canada $0.187B 0.00
Biote (BTMD) United States $0.181B 4.12
TriSalus Life Sciences (TLSI) United States $0.175B 0.00
Utah Medical Products (UTMD) United States $0.172B 13.24
Brainsway (BWAY) Israel $0.155B 48.47
Jin Medical (ZJYL) China $0.147B 0.00
Organigram Global (OGI) Canada $0.135B 0.00
FitLife Brands (FTLF) United States $0.123B 15.42
Agape ATP (ATPC) $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Quipt Home Medical (QIPT) United States $0.086B 0.00
TerrAscend (TSNDF) Canada $0.083B 0.00
Exagen (XGN) United States $0.080B 0.00
MacroGenics (MGNX) United States $0.079B 0.00
Veru (VERU) United States $0.078B 0.00
Fonar (FONR) United States $0.076B 10.65
Zynex (ZYXI) United States $0.066B 24.22
United Health Products (UEEC) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.064B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
InterCure (INCR) Israel $0.063B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
United-Guardian (UG) United States $0.038B 11.61
Apyx Medical (APYX) United States $0.037B 0.00
Modular Medical (MODD) United States $0.036B 0.00
Rockwell Medical (RMTI) United States $0.035B 51.50
Safety Shot (SHOT) United States $0.033B 0.00
Nephros (NEPH) United States $0.021B 0.00
INLIF (INLF) $0.018B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
Flora Growth (FLGC) United States $0.010B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00